CNPOF - Canopy Rivers Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
1.7800
+0.0186 (+1.06%)
At close: 3:57PM EDT
Stock chart is not supported by your current browser
Previous Close1.7614
Open1.7000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.7000 - 1.8700
52 Week Range1.7000 - 7.3016
Volume107,184
Avg. Volume107,953
Market Cap329.417M
Beta (3Y Monthly)N/A
PE Ratio (TTM)6.85
EPS (TTM)0.2600
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Canopy Rivers' thriving ecosystem demonstrated by purchase and supply agreement between portfolio companies
    CNW Group

    Canopy Rivers' thriving ecosystem demonstrated by purchase and supply agreement between portfolio companies

    JWC AND TERRASCEND SIGN MUTUALLY BENEFICIAL PURCHASE AND SUPPLY CONTRACT TORONTO , Aug.15, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company" ) (TSXV: RIV) (OTC: CNPOF) ...

  • Canopy Rivers to Report First Quarter Fiscal Year 2020 Financial Results and Host Earnings Call
    CNW Group

    Canopy Rivers to Report First Quarter Fiscal Year 2020 Financial Results and Host Earnings Call

    TORONTO, Aug. 13, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) will report its first quarter fiscal year 2020 financial results before markets open on Tuesday, August 27, 2019. The Company's unaudited condensed interim financial statements and Management's Discussion and Analysis for the three months ended June 30, 2019 will be available on the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's website at www.canopyrivers.com/investors/financials-and-public-filings. Certain preliminary financial information pertaining to the Company may also be found in the financial results released by Canopy Growth Corporation (TSX:WEED.TO - News) (NYSE:CGC - News), which are currently scheduled to be released on August 14, 2019.

  • Canopy Rivers receives conditional approval to graduate to the Toronto Stock Exchange
    CNW Group

    Canopy Rivers receives conditional approval to graduate to the Toronto Stock Exchange

    TORONTO, Aug. 12, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to announce that it has received conditional approval from the Toronto Stock Exchange (the "TSX") to graduate from the TSX Venture Exchange (the "TSXV") and list its class A subordinated voting shares (the "Subordinated Voting Shares") on the TSX.

  • Canopy Rivers Portfolio Company YSS Receives 12th Cannabis Retail Licence in Alberta
    CNW Group

    Canopy Rivers Portfolio Company YSS Receives 12th Cannabis Retail Licence in Alberta

    TORONTO, Aug. 8, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) congratulates its portfolio company, YSS Corp. ("YSS") (TSXV:YSS) (WKN:A2PMAX), on receiving its 12th cannabis retail licence from the Alberta Gaming, Liquor and Cannabis Commission ("AGLC"). Operating under the YSS™ brand name, the newly licensed store is strategically located in a high-traffic suburban area in northwest Edmonton. YSS has six operational stores located in Calgary and Red Deer, with an additional two licensed locations expected to open in Vermilion and Vegreville within the next week.

  • Canopy Rivers Portfolio Company Terrascend Announces Acquisition of Vertically-Integrated Pennsylvania Cannabis Operator
    CNW Group

    Canopy Rivers Portfolio Company Terrascend Announces Acquisition of Vertically-Integrated Pennsylvania Cannabis Operator

    TORONTO, Aug. 6, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to announce its portfolio company, TerrAscend Corp. ("TerrAscend") (CSE:TER.CN - News) (OTCQX:TRSSF - News), has signed a definitive agreement to acquire Ilera Healthcare ("Ilera"), a vertically-integrated cannabis cultivator, processor, and dispensary operator in Pennsylvania. Ilera's state-of-the-art, fully integrated seed-to-sale operations adds to TerrAscend's growing global footprint, currently spanning multiple U.S. states, Canada and the European Union. "TerrAscend's rapid expansion in the U.S. has been driven by strategic, accretive acquisitions of quality operators with strong track records of success," said Narbe Alexandrian, President and CEO of Canopy Rivers.

  • Canopy Rivers Announces Health Canada Approval for Significant Expansion to the Licensed Infrastructure at Radicle
    CNW Group

    Canopy Rivers Announces Health Canada Approval for Significant Expansion to the Licensed Infrastructure at Radicle

    TORONTO, Aug. 1, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to announce that its portfolio company Radicle Medical Marijuana Inc. ("Radicle") has received approval from Health Canada for its production facility expansion project. This approval effectively doubles Radicle's production footprint, significantly increasing its capacity to 6,000 kilograms per year. "We are thrilled with the continued growth happening at Radicle," said Narbe Alexandrian, President and CEO of Canopy Rivers.

  • Canopy Rivers' Flagship PharmHouse JV Licensed By Health Canada
    CNW Group

    Canopy Rivers' Flagship PharmHouse JV Licensed By Health Canada

    TORONTO, July 22, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to announce that its 49%-owned joint venture, PharmHouse Inc.  ("PharmHouse"), has received a cultivation licence from Health Canada. PharmHouse will be immediately commencing operations in 190,000 sq. ft. of licensed nursery infrastructure and plans to ramp up the entire 1.3 million sq. ft. ultramodern greenhouse before the end of 2019 to deliver low-cost and high-quality cannabis and cannabis derivative products to the Canopy Rivers ecosystem of partners, both domestically and internationally. "This is a significant corporate milestone for Canopy Rivers.

  • Canopy Rivers Reports Fourth Quarter and Fiscal Year 2019 Financial Highlights and Provides Corporate Update
    CNW Group

    Canopy Rivers Reports Fourth Quarter and Fiscal Year 2019 Financial Highlights and Provides Corporate Update

    TORONTO, July 16, 2019 /CNW/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSXV:RIV.V - News) (OTC:CNPOF - News) today released its financial results for the three and twelve months ended March 31, 2019. The Company's audited consolidated financial statements for the twelve months ended March 31, 2019, and its full Management's Discussion and Analysis (the "MD&A") for the three and twelve months ended March 31, 2019, are available under the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's website at www.canopyrivers.com/financials. "It was a year full of milestones and significant achievements for Canopy Rivers," said Narbe Alexandrian, President and Chief Executive Officer of Canopy Rivers.

  • Canopy Rivers portfolio company YSS receives five new cannabis retail licences in Alberta
    CNW Group

    Canopy Rivers portfolio company YSS receives five new cannabis retail licences in Alberta

    TORONTO , July 9, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSXV: RIV) (OTC: CNPOF) congratulates its portfolio company, YSS Corp. (" YSS ") ...

  • Canopy Rivers Portfolio Company Receives Key Licence Amendment from Health Canada
    CNW Group

    Canopy Rivers Portfolio Company Receives Key Licence Amendment from Health Canada

    TORONTO, July 8, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to share that its portfolio company, James E. Wagner Cultivation Corporation ("JWC") (TSXV:JWCA.V - News) (OTCQX:JWCAF - News), has received approval of a licence amendment from Health Canada. This licence amendment allows for the sale of formulated cannabis oil from JWC's pilot facility in Kitchener, Ontario.

  • Canopy Rivers Portfolio Company Terrascend Receives Cannabis Oil Sales Licence in Canada
    CNW Group

    Canopy Rivers Portfolio Company Terrascend Receives Cannabis Oil Sales Licence in Canada

    TORONTO , July 8, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSXV: RIV) (OTC: CNPOF) congratulates its portfolio company TerrAscend Corp. (" TerrAscend ...

  • CNW Group

    Canopy Rivers Announces Change to Board of Directors

    TORONTO , July 3, 2019 /CNW/ - Further to Canopy Growth Corporation's press release today, Bruce Linton has also stepped down as Chairman and Director of Canopy Rivers Inc. (the "Company" or ...

  • CNW Group

    Canopy Rivers to Report Fourth Quarter and Fiscal Year 2019 Financial Results

    TORONTO, June 19, 2019 /CNW/ - Canopy Rivers Inc. (the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) will report its financial results for the fourth quarter and fiscal year ended March 31, 2019 before markets open on Tuesday, July 16, 2019. The Company's audited consolidated financial statements and Management's Discussion and Analysis for the three and twelve months ended March 31, 2019 will be available on the Company's profile on SEDAR at www.sedar.com and in the Investors section of the Company's website at www.canopyrivers.com. Certain preliminary financial information pertaining to the Company may also be found in the financial results released by Canopy Growth Corporation (TSX: WEED, NYSE: CGC), which are currently scheduled to be released on June 20, 2019.

  • Canopy Rivers Makes US$10 Million Investment in Plant Genetics Innovator ZeaKal
    CNW Group

    Canopy Rivers Makes US$10 Million Investment in Plant Genetics Innovator ZeaKal

    TORONTO and SAN DIEGO, June 19, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers", the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) and ZeaKal, Inc. ("ZeaKal") are pleased to announce an investment and strategic collaboration between Canopy Rivers and ZeaKal, a California-based plant science innovator with proprietary technologies that sustainably increase photosynthesis, improve plant yield and enhance nutritional profiles for a variety of agricultural crops. The investment from Canopy Rivers marks another significant corporate milestone this calendar year for ZeaKal, following the February announcement of its R&D collaboration (link) with Corteva Agriscience (NYSE:CTVA), the recently spun-out and NYSE-listed agricultural science division of DowDuPont.

  • CNW Group

    Canopy Rivers announces grant of options

    TORONTO , June 13, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSXV: RIV) (OTC: CNPOF) has granted incentive stock options under the Company's stock option ...

  • Canopy Rivers Hosts Analyst and Investor Day on May 28 - Live Webcast Available
    CNW Group

    Canopy Rivers Hosts Analyst and Investor Day on May 28 - Live Webcast Available

    TORONTO, May 28, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News), (OTC:CNPOF - News) will be hosting its analyst and investor day from 1:00 p.m. to 5:00 p.m. ET today, May 28. The webcast will be available on Canopy Rivers' website immediately prior to the event at www.canopyrivers.com/investors/events. Bruce Linton, Chairman of the Board, will share his perspective on Canopy Rivers' unique value proposition.  This will be followed by a presentation from senior executives addressing Canopy Rivers' priorities in support of its mission to accelerate success in the global cannabis economy.

  • CNW Group

    Canopy Growth subsidiary and Canopy Rivers portfolio company Vert Mirabel now fully licensed by Health Canada

    Final 190,000 sq. ft. Greenhouse Licensed. Total of 700,000 sq. ft. of Production and Processing Infrastructure Now Fully Licensed MIRABEL, QC , May 28, 2019 /CNW/ - Les Serres Vert Cannabis Inc. ("Vert ...

  • Canopy Rivers Hosts analyst and Investor Day
    CNW Group

    Canopy Rivers Hosts analyst and Investor Day

    TORONTO , May 23, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSXV: RIV) (OTC: CNPOF) today announced that it will host an analyst and investor day on Tuesday, ...

  • Canopy Rivers Portfolio Company Agripharm Awarded Outdoor Cultivation Licence
    CNW Group

    Canopy Rivers Portfolio Company Agripharm Awarded Outdoor Cultivation Licence

    TORONTO, May 21, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to share that its portfolio company, Agripharm Corp. ("Agripharm"), has received its outdoor cultivation license from Health Canada. "We are pleased to see Agripharm diversify its operations and increase its growing capacity with the grant of this outdoor cultivation licence," said Oliver Dufourmantelle, Chief Operating Officer of Canopy Rivers. Founded in 2013, Agripharm is home to both the first cannabis production facility built from the ground up and the first supercritical CO2 extraction lab in Canada.

  • CNW Group

    Cannastocks2019 Investor Conference & Webinar Now Available for On-Demand Viewing

    Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations NEW YORK , May 17, 2019 /CNW/ - Virtual Investor Conferences, in ...

  • Canopy Rivers Backs BioLumic - Shines Light on New AgTech for the Medical Cannabis Industry
    CNW Group

    Canopy Rivers Backs BioLumic - Shines Light on New AgTech for the Medical Cannabis Industry

    TORONTO and PALMERSTON NORTH, New Zealand, May 15, 2019 /CNW/ - BioLumic Ltd. ("BioLumic"), creators of a sustainable ultraviolet (UV) crop yield enhancement system, and Canopy Rivers Inc. ("Canopy Rivers") (TSXV:RIV.V - News), (OTC:CNPOF - News) today announced a strategic investment from Canopy Rivers. BioLumic extended the Finistere Ventures-led Series A financing round to include Canopy Rivers' strategic investment of US$1.5 million, closing the oversubscribed round at US$6.7 million. This marks Canopy Rivers' first investment in agri-technologies, specifically focused on the promising fields of plant physiology and UV photobiology.

  • CNW Group

    Cannastocks2019 Live-Stream Investor Conference & Webinar May 15th

    Public Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com NEW YORK , May 14, 2019 /CNW/ - Virtual Investor Conferences, in partnership with Midtown Partners ...

  • Canopy Rivers Announces Significant Supply Agreement Between PharmHouse and Canopy Growth
    CNW Group

    Canopy Rivers Announces Significant Supply Agreement Between PharmHouse and Canopy Growth

    TORONTO, May 9, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to announce that its portfolio company PharmHouse Inc. ("PharmHouse") has entered into a second offtake agreement (the "Agreement") with Canopy Growth Corporation ("Canopy Growth") (TSX:WEED.TO - News) (NYSE:CGC - News) for the purchase of cannabis from its 1.3 million square foot greenhouse facility upon licensing. The Agreement commits an additional 20% of PharmHouse's flowering space to Canopy Growth for the next three years, in addition to the 10% that was originally committed in May 2018.

  • Canopy Growth announces offtake agreement with PharmHouse
    CNW Group

    Canopy Growth announces offtake agreement with PharmHouse

    SMITHS FALLS, ON, May 9, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED.TO - News) (NYSE:CGC - News) is pleased to announce today that has signed an offtake agreement with PharmHouse Inc. ("PharmHouse"), a 49 per cent-owned joint venture of Canopy Rivers Inc. (TSXV:RIV.V - News) (OTC:CNOPOF). Under the terms of the agreement, PharmHouse has agreed to allocate high quality cannabis flower from an additional 20 per cent of the flowering space available at its Leamington greenhouse facility over the next three years. Boasting 1.3 million square feet of greenhouse grow space, and leveraging the resources of Canopy Growth, Canopy Rivers and its joint venture partner have worked diligently since October 2018 to prepare the facility for licensing.  PharmHouse will leverage Canopy Growth's genetics – selected and supplied by the Company – and flower will be returned to the Company to be sold under Canopy Growth's diverse brands and banners.  Under the terms of the new offtake agreement, PharmHouse is committed to producing GMP-certified, high quality cannabis flower within 18 months of its cultivation license and the flower must comply with the Company's high standards for cannabis quality.

  • Canopy Rivers congratulates TerrAscend on receiving its EU GMP certification and new distribution agreement
    CNW Group

    Canopy Rivers congratulates TerrAscend on receiving its EU GMP certification and new distribution agreement

    TORONTO, May 3, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) congratulates its portfolio company TerrAscend Corp. ("TerrAscend") (CSE:TER.CN - News) (OTCQX:TRSSF - News) on its announcement yesterday that its facility in Mississauga, Ontario, Canada has been issued a Good Manufacturing Practice ("GMP") certificate in accordance with the rules governing medicinal products in the European Union ("EU"). Only medical cannabis from EU GMP certified facilities, or the equivalent, may be sold in the EU. The regulatory approach has been led by several of the larger EU countries and as such, pharmaceutical grade controls in production were an established requirement from the onset of medical cannabis legalization.